Stem-cell-like CD4+ T cells prey on MHC class II-negative tumors

Nat Immunol. 2023 Aug;24(8):1212-1214. doi: 10.1038/s41590-023-01563-5.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • CD4-Positive T-Lymphocytes
  • Genes, MHC Class II*
  • Histocompatibility Antigens Class II
  • Humans
  • Neoplasms*

Substances

  • Histocompatibility Antigens Class II